The AACR Annual Meeting highlights the latest findings in all major areas of cancer research. The theme of the AACR Annual Meeting 2013, “Personalizing Cancer Care Through Discovery Science,” reflects the accelerating pace of discoveries in the basis, translational and clinical sciences. Due in large part to the advent of new technologies, cancer researchers are making rapid progress that has significant patient benefit.
Five press conferences will be held during the meeting and recordings will be posted here as they become available.
“Late Breaking Clinical Trials,” Saturday, April 6, hosted by AACR President-elect Charles L. Sawyers, M.D., chair of the Human Oncology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center, New York, N.Y.
“Genomics and Predictors of Outcome,” Saturday April 6, hosted by Giuseppe Giaccone, M.D., Ph.D., associate director for clinical research at Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C.
“Treatment and Resistance to Targeted Therapies,” Sunday, April 7, hosted by Levi Garraway, M.D., Ph.D., assistant professor of medicine in the department of medical oncology at the Dana-Farber Cancer Institute, Boston, Mass.
“Stand Up To Cancer,” Sunday, April 7, announced the four-year results of the first five Dream Teams and the formation of a new Dream Team in partnership with St. Baldrick’s Foundation, which will focus on pediatric cancer
“AACR Policy Statement on Tobacco,” Tuesday, April 9, hosted by Roy Herbst, M.D. Ph.D., chair of the AACR Subcommittee on Tobacco and Cancer and chief of medical oncology at Yale Comprehensive Cancer Center in New Haven, Conn.
Updated: April 9, 2013